Drug-Drug Interaction Between THC and AEF0117

Summary

This trial is a single center, double blind, placebo-controlled trial in healthy male and female recreational cannabis users with placebo and AEF0117 dosed in a fixed sequence. The goal of this clinical trial is to investigate if AEF0117 has any effect on the pharmacokinetics of THC and its metabolites when smoking cannabis.

Timeline

Start

2025-12

Primary completion

2026-06

Completion

2026-06

Outcome

Outcome not reported

Stopped: “Due to several issues, this study has never been submitted to the IRB. So the sponsor was decided to withdraw it.”

Drugs

Indications